Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 616452 Compound
2. E 616452
3. E-616452
4. E616452
1. 446859-33-2
2. Alk5 Inhibitor Ii
3. 2-(3-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl)-1,5-naphthyridine
4. Alk5 Inhibitor
5. Sjn 2511
6. Repsox (gmp)
7. E-616452
8. 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]-1,5-naphthyridine
9. 2-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-1,5-naphthyridine
10. Gw786460x
11. Chembl185238
12. Sjn-2511
13. 1,5-naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl]-
14. 2-(3-(6-methylpyridine-2-yl)-1h-pyrazol-4-yl)-1,5-naphthyridine
15. 2-(3-(6-methyl-2-pyridinyl)-1h-pyrazol-4-yl)-1,5-naphthyridine
16. 2-[3-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-1,5-naphthyridine
17. 1vjy
18. Alk 5 Inhibitor Ii
19. Repsoxalk5 Inhibitor Ii
20. Mls006011123
21. Schembl144632
22. Repsox (alk5 Inhibitor Ii)
23. Schembl16969100
24. Alk5 Inhibitor Ii Hydrochloride
25. Repsox, >=98% (hplc)
26. Dtxsid80332295
27. Chebi:190969
28. Hms2043p13
29. Hms3261n03
30. Hms3653m19
31. Amy20099
32. Bcp04103
33. Ex-a2879
34. Tox21_500541
35. Bdbm50151347
36. Hy-13012g
37. Mfcd09037561
38. Nsc756354
39. S7223
40. Zinc16052804
41. Akos016009677
42. Bcp9000274
43. Ccg-221845
44. Cs-1321
45. Nsc-756354
46. Ncgc00242054-01
47. Ncgc00242054-02
48. Ncgc00242054-03
49. Ncgc00242054-17
50. Ncgc00261226-01
51. Ac-28395
52. As-16653
53. Da-42419
54. Hy-13012
55. Smr004702903
56. Bcp0726000102
57. Cs-0617970
58. Ft-0759246
59. R0224
60. Sw212662-2
61. J3.496.867e
62. Ab01092249-01
63. Gw786460x (616452)
64. J-507645
65. 3-(2-carboxyethyl)-2,5-dimethylbenzoxazoliumbromide
66. 2-[3-(6-methyl-2-pyridyl)-1h-pyrazole-4-yl]-1,5-naphthyridine
67. 2-[3-(6-methyl-pyridin-2-yl)-1h-pyrazol-4-yl]-[1,5]naphthyridine
68. E-616452;sjn 2511;e616452;sjn2511;e 616452;sjn-2511
| Molecular Weight | 287.32 g/mol |
|---|---|
| Molecular Formula | C17H13N5 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 287.11709544 g/mol |
| Monoisotopic Mass | 287.11709544 g/mol |
| Topological Polar Surface Area | 67.4 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 376 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
96
PharmaCompass offers a list of Repsox API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Repsox manufacturer or Repsox supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Repsox manufacturer or Repsox supplier.
PharmaCompass also assists you with knowing the Repsox API Price utilized in the formulation of products. Repsox API Price is not always fixed or binding as the Repsox Price is obtained through a variety of data sources. The Repsox Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Repsox manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Repsox, including repackagers and relabelers. The FDA regulates Repsox manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Repsox API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Repsox supplier is an individual or a company that provides Repsox active pharmaceutical ingredient (API) or Repsox finished formulations upon request. The Repsox suppliers may include Repsox API manufacturers, exporters, distributors and traders.
Repsox Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Repsox GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Repsox GMP manufacturer or Repsox GMP API supplier for your needs.
A Repsox CoA (Certificate of Analysis) is a formal document that attests to Repsox's compliance with Repsox specifications and serves as a tool for batch-level quality control.
Repsox CoA mostly includes findings from lab analyses of a specific batch. For each Repsox CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Repsox may be tested according to a variety of international standards, such as European Pharmacopoeia (Repsox EP), Repsox JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Repsox USP).
